Search

Your search keyword '"Edelstein, Howard"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Edelstein, Howard" Remove constraint Author: "Edelstein, Howard"
118 results on '"Edelstein, Howard"'

Search Results

1. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study

2. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study

5. Factors Associated With Retention Among Non–Perinatally HIV-Infected Youth in the HIV Research Network

11. Pulmonary aspergillosis in the acquired immunodeficiency syndrome

13. Mycobacterium marinum skin infections: report of 31 cases and review of the literature

17. Discontinuity in Medicaid Coverage Among Young Adults with HIV.

18. Disability plans for executives

19. Efficacy and Safety of Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 48: Subgroup Analysis of a Randomized Switch Study

20. Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials

21. Power of Supplemental Pension Plans

22. Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection

23. Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial

24. Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.

26. Nonqualified retirement plans take on increased importance in estate planning.

30. DMZ paradox

32. Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.

44. Executive bashing

45. Securities trade processors seek details on Swift plan

48. Letters and Corrections.

49. The Changing Landscape of Executive Retirement Plans.

50. Intravenous or Intramuscular Teicoplanin Once Daily for Skin and Soft-Tissue Infections

Catalog

Books, media, physical & digital resources